Prediction of acute and chronic complications by a new computer simulation model for type 1 and type 2 diabetes: the Diabetes Mel l it us Model (DMM)

References

• Ruigomez A, Garcia Rodriguez LA. Presence of diabetes related complication at the time of NIDDM diagnosis: an important prognostic factor. European Journal of Epidemiology 1998; 14: 439–445.
   Google Scholar
• UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Research 1990; 13: 1–11.
   PubMedGoogle Scholar
• Coyle D, Lee KM, O’Brien BJ. The role of models within economic analysis: focus on type 2 diabetes mellitus. PharmacoEconomics 2002; 20(Suppl 1): 11–19.
   Google Scholar
• Klein R, Klein BE, Moss SE et al. Prevalence of diabetes mellitus in southern Wisconsin. American Journal of Epidemiology 1984; 119: 54–61.
   Google Scholar
• The effect of intensive treatment of diabetes on the development and progression of long- term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine 1993; 329: 977– 986.
   Google Scholar
• Klein R, Moss S. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Archives of Internal Medicine 1995; 155: 745– 754.
   Google Scholar
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837– 853. [Erratum. Lancet 1999; 354: 602.]
   Google Scholar
• Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994; 101: 1061–1070.
   PubMed Web of Science ®Google Scholar
• Chamberlain H. Musical Applications of Microprocessors, 2nd edn. Hasbrouck Heights, NJ: Hayden Book Company, 1985.
   Google Scholar
• Ranlux J. A Fortran implementation of the high-quality pseudorandom number generator. Computer Physics Communications 1994; 79: 111–114.
   Google Scholar
• Ranlux J. A Fortran implementation of the high-quality pseudorandom number generator of Lüscher. Computer Physics Communications 1996; 97: 357.
   Google Scholar
• Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Annals of Internal Medicine 1997; 127: 788–795.
   PubMed Web of Science ®Google Scholar
• Ahrens J, Dieter U. Extensions of Forsythe’s method for random sampling from the Normal distribution. Math Comput 1973; 27: 927–937.
   Google Scholar
• Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997; 46: 271–286.
   Google Scholar
• Turner RC, Millns H, Neil HA et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: 823–828.
   Google Scholar
• Klein R, Klein BE, Moss SE et al. The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 1999; 22: 743– 751.
   Google Scholar
• Stratton I, Adler A, Neil A et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–412.
   Google Scholar
• Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412–419.
   Google Scholar
• The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995; 44: 968–983.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995; 102: 7–16.
   Google Scholar
• Klein R, Klein BE, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105: 1801–1815.
   PubMed Web of Science ®Google Scholar
• Moy CS, Songer TJ, LaPorte RE et al. Insulin- dependent diabetes mellitus, physical activity, and death. American Journal of Epidemiology 1993; 137: 74–81.
   Google Scholar
• LaPorte RE, Dorman JS, Tajima N et al. Pittsburgh Insulin-Dependent Diabetes Mellitus Morbidity and Mortality Study: physical activity and diabetic complications. Pediatrics 1986; 78:1027–1033.
   Google Scholar
• Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998; 105: 998– 1003.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–713.
   Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Annals of Internal Medicine 1995; 122: 561–568.
   Google Scholar
• Moss SE, Klein R, Klein BE. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1999; 22: 951–959.
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. The prevalence and incidence of lower extremity amputation in a diabetic population. Archives of Internal Medicine 1992; 152: 610–616.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 1991; 34: 877–890.
   Google Scholar
• Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. American Journal of Public Health 1991; 81: 1158–1162.
   PubMed Web of Science ®Google Scholar
• Maxion-Bergemann S, Walleser S, Müller E et al. Diabetes Mellitus Model (DMM): internal validation of a aomputer-simulation model for type 1 and type 2 diabetes. Journal of Medical Economics 2006; 9: 69–82.
   Google Scholar
• Javitt JC. Cost savings associated with detection and treatment of diabetic eye disease. PharmacoEconomics 1995; 8(Suppl 1): 33–39.
   Google Scholar
• Eastman RC, Javitt JC, Herman WH et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 1997; 20: 725–734.
   Google Scholar
• Eastman RC. Cost-effectiveness of treatment of type 2 diabetes. Diabetes Care 1998; 21: 464–465.
   Google Scholar
• Brown JB, Russell A, Chan W et al. The global diabetes model: user friendly version 3.0. Diabetes Research and Clinical Practice 2000; 50(Suppl 3): S15–S46.
   Google Scholar
• Palmer AJ, Weiss C, Sendi PP et al. The cost- effectiveness of different management strategies for type I diabetes: a Swiss perspective. Diabetologia 2000; 43: 13–26.
   Google Scholar
• Palmer AJ, Sendi PP, Spinas GA. Applying some UK Prospective Diabetes Study results to Switzerland: the cost-effectiveness of intensive glycaemic control with metformin versus conventional control in overweight patients with type-2 diabetes. Schweizerische Medizinische Wochenschrift 2000; 130: 1034– 1040.
   PubMedGoogle Scholar
• Resource utilization and costs of care in the diabetes control and complications trial. Diabetes Care 1995, 18: 1468–1478.
   Google Scholar
• D’Agostino RB, Russell MW, Huse DM et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. American Heart Journal 2000; 139(2 Pt 1): 272–281.
   PubMed Web of Science ®Google Scholar
• Cupples LA, D’Agostino RB, Kiely D. The Framingham Heart Study, Section 35. An Epidemiological Investigation of Cardiovascular Disease. Survival Following Cardiovascular Events: 30 Year Follow-up. Bethesda, MD: National Heart, Lung and Blood Institute, 1988.
   Google Scholar
• Wolf PA, D’Agostino RB, Belanger AJ et al. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 22: 312–318.
   Google Scholar